Elanco is a public animal health company that develops pharmaceuticals, vaccines, parasiticides, and nutrition products for pets and farm animals, sold through veterinarians, distributors, and retail channels. Headquartered in Indianapolis and traded on the NYSE (ELAN), it originated at Eli Lilly in 1954 and became an independent company in 2018. Elanco expanded its portfolio by acquiring Bayer Animal Health in 2020, serving companion-animal and livestock markets worldwide.